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SUMMARY
Three test series involving173 man tests were Conducted in the process
of defining and verifyinga pre-extravehicularactivity (EVA) denitrogenation
procedurethat would provideacceptableprotectionagainstaltitudedecompres-
sion sicknesswhile minimizingthe requireddurationof oxygen (02) prebreathe
in the suit prior to EVA. The tests also addressedthe safety, in terms of
incidenceof decompressionsickness,of conducting EVA's on consecutivedays
ratherthan on alternatedays.
The tests were conductedin an altitude chamber, subjectswere selected
as representativeof the astronautpopulation,and EVA periodswere simulated
" by reducingthe chamber pressureto suit pressurewhile the subjectsbreathed
02 with masks and worked at EVA representativework rates. The measured para-
meterswere the presenceand grade of venous bubbles as measured by a doppler
bubble detector and the presenceand grade of symptomsof decompressionsick-
ness reportedby the subjects.
A higher than anticipated incidence of both venous bubbles (55%) and
symptoms (26%) was measured followingall denitrogenationprotocols in this
test. For the most part, symptomswere very minor and stabilized,diminished,
or disappearedin the 6-hour Series3 Tests. Instancesof clear, possible,or
potentialsystemic symptomswere encounteredonly after use of the unmodified
10.2 psi protocoland not after the modified 10.2 psi protocol,the 3.5-hour
02 prebreathe protocol, or the 4.0-hour 02 prebreathe protocol. The high
incidenceof symptomsis ascribedto the type and durationof exerciseand the
sensitivityof the reportingtechniqueto minor symptoms. RePeated EVA expo-
sures after only 17 hours did not increasesymptomor bubble incidence.
The modified 10.2 psi denitrogenationprovided protectionequivalent or
better than that providedby current insuit02 prebreatheprocedures.
Repetition of a decompressionafter 17 hours did not increasethe inci-
dence of symptomsof decompressionsickness or of venous bubbles. The inci-
dence of altitude decompressionsickness,although very mild, indicatesthe
possibilityof more serious responsesand the need to pursue and prepare pro-
ceduresfor inflighttreatmentof decompressionsickness.
INTRODUCTION
The advent of a 14.7 psi cabin atmospherein Shuttleincreasedthe poten-
tial for altitudedecompressionsicknessto occur while performingextravehic-
ular activity (EVA) at reducedpressure. Each time an EVA is conducted,there
is a change in pressure and this is the provocativeevent in decompression
sickness.
Altitude decompressionsickness occurs when the sum of the dissolved
gases in in the body tissues exceed the ambient pressure to the extent that
bubbles grow and proliferatein the tissues. In practice,the principalgas
of concern when crewmen are breathingair or an 02/N2 mixture is nitrogen.
Breathing02 prior to EVA is an effectivemeans of reducing tissue N2 pres-
sure. Tissue N2 can also be reducedby breathingan atmosphere in which N2
pressure is reduced as a function of a reducedtotal pressure or a reduced
percent compositionof N2. A denitrogenationprotocol based on the latter
concept is desirablefor operationalShuttle flightsto precludethe necessity
for a long (3-4 hrs) prebreathe in the pressure suit. An earlier study veri-
fied the acceptabilityof a 9.0 psi decompressionstop denitrogenationproced-
ure for the OrbitalFlight Test Program (1).
This report presents the results of three series of altitude chamber
tests conducted to verify the operationalacceptabilityof denitrogenation
protocolsutilizing a 12-hour staged decompressionto 10.2 psi with 74% N2
combined with short 02 prebreathetimes. The protocol is evaluatedin terms
of its effectivenessin preventingaltitudedecompressionsicknessduring sim- s
ulated EVA at 4.3 psi suit pressures. Limitationsof this protocoland other
availabledenitrogenationprotocolsin preparationfor repeated exposuresto
EVA are also addressed.
METHODS
Series 1 Protocol. Thirty-sixmale subjects,selectedto be representa-
tive of the astronautpopulationin age, lean to fat ratio, and level of exer-
cise (Table I), were exposed to variationsof a stage decompressionprotocol
involving a 12-hour stay at a 10.2 psi cabin pressure and a short 02 pre-
breathefollowedby decompressionto 4.3 psi.
The tests were conductedin an altitude chamber with the general volume
and geometry of the Shuttlemid-deck area. Subjectswere exposedto the test
protocol three at a time. The subjects entered the chamber after an evening
meal. The chamber atmospherewas reducedto a pressure of 10.2 psi with 74%
N2 and maintainedat this level. Sleepingpalletswere provided in the cham-
ber and the 12-hour stay at the decompressionstop includedan 8-hour sleep
period. After a light breakfastand upon completionof the 12-hour period,
the subjectsdonned masks and breathed 100% 02 for the remainderof the test.
After the subjects had breathed 02 for 40 minutes, the chamber pressure was
reducedto 4.3 psi to simulatethe pressuresuit pressureduringEVA.
During the subsequent3-hour period,the subjects simulatedthe EVA work
period by a repeated 16-minutecycle of upper body exercise (liftinga small
weight), lower body exercise (steppingon a 7 1/2 in. step), rest, and doppler
sensor monitoring. The work period was 8 minutes in each 16 minutes and
measurementof 02 consumptionon several subjects indicatedan average meta-
bolic rate during the work periods of 200 Kcal/hr. The method of doppler
sensor monitoring was that described by Adams, et al (2), and the method of
bubble gradingwas that describedby Neuman,et al (3).
Three of the 36 subjectswere exposedto the test protocoltwice, result-
ing in a total of 39 man exposures. Variations of the protocol described,
included an increaseof the period of time at 10.2 psi to 18 hours, and an
increase of the final 02 prebreathe from 40 minutes to 90 minutes, and
finally,exposureof 11 subjectsto a 3.5 hour prebreathat 14.7 psi prior to
the decompressionto 4.3 psi. _ubjects were removed from the chamberat the
first indicationof altitudedecompressionsickness.
Series 2 Protocol. This serieswas conductedspecificallyto comparethe
10.2 psi stage decompressionprotocolwith a 3.5 hour 02 prebreathe. Nineteen
male subjectswere selectedat random from those completingthe Series 1 tests
and'4new male subjectswere used. Twenty'oneof the subjectswere exposedto
both the 10.2 psi protocol and a 3.5 hour prebreatheprotocolprior to decom-
pression to the 4.3 psi simulated EVA. A total of 44 man tests were
conducted.
!
, Series 2 tests were conductedlike the Series 1 tests with the following
changes:
• a. The type of exercisewas changedfrom a step test thatemphasized use
_e
of anti-gravitymuscles and concentratedstress on a single joint to an exer-
cise protocol that involved 3 diverse upper body exercises in two seperate
modes of operationthat were deemed by the investigatorsand crew representa-
tives as being representativeof extravehicularactivities (EVA). Exercise
activitiesare shown in Figures1 and 2. -.
b. A revised decompressionsickness grading scale for limb bends was
utilized,and the criticallevel for test cessationwas changed from identifi-
cation of aches, pains,or discomfortsymptomaticofdecompressionsicknessto
the presence of clear limb pain associatedwith a decrementin performance.
°c. A researchmask replacedthe Air Force mask used on the first test
series, The use of this mask and the pre-testverificationof zero N2 leakage
with this mask with a mass spectrometerinsuredthat there was no break in the
prebreatheperiodsprescribedby the two test protocols. (Table2)
d. Each subjectwas exposedto two test protocols;the 10.2 psi protocol
and a 3.5-hour02 prebreatheprotocolso that the responsesof the subjectson
the 110.2psi protocolcould be comparedwith their responseto a protocolwith
a historyof operationaleffectiveness.
,The 10.2 psi protocolinvolveda period of 12 hours at a pressureof 10.2
psi with an 02 concentrationof 26%. This was followedby a period of breath-
ing 02 for 40 minutes at 10.2 psia, followed by a decompressionto 4.3 psi
over a 30-minuteperiod representativeof the operationalchange of pres-
sure in the pressuresuit prior to and during the first few minutes of an EVA
(Figure3a). _.
TThe 3.5-hour prebreathe protocol involved a period of 3.5 hours at sea
level pressureLbreathing02 suppliedto the researchmask prior to the 30-
minute period of decompressionto a 4.3 psi pressure representativeof EVA
pres'suresuit pressure. (Figure3b)
Followingeither prebreathe protocol, the subjects worked for 4 hours
doing tasks to simulate EVA exercise. The first 10 minutes of this period
began at a pressure of 5.3 psia which decreasedto 4.3 psia as would occur
during an operationalEVA. The remainderof the 4.0-hour period was at a 4.3
psia pressure. The activity during this 4.0-hour period involved a 4-minute
period of work on an arm crankingdevice,a 4-minute period oftime workingon
a rope pull device,a 4-minuteperiodof time working at a torque stand torqu-
ing against fixed studs, and a 4-minute period in which the subject was
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monitored with a doppler bubble detector while the subjectflexed his four
limbs in sequence. The three exerciseswere then repeatedwith some change in
the exercise at each exercise stand. After the second dopplermonitoring in
the sequence,a 4-minute rest period was taken by the subject. A complete
sequenceinvolvedsix 4-minuteexerciseperiods,two 4-minutedopplermeasure-
ments, and one 4-minute rest period. This sequence was repeated until the
4.0-hourexercise period was complete. Each subject experiencedthe 4.0-hour
exercise period in the laboratory at sea level so they could identify any
symptomsgeneratedby muscle strain and so that measurementsof the work rate
could be made.
The subjectswere encouragedto report any symptomsat the time of occur-
rence, and in addition,a formal question regardingthe presenceof any symp-
toms was asked at the beginningof the test and at the end of each 1-hour
Period.
Series 3 Protocol. In this test series,the 10.2 psi protocolwas modi-
fied to includea 60-minute02 prebreatheprior to the initialchange in pres-
sure from 14.7 psi to 10.2 psi (Figure3c). This additionwas made to avoid
the growth or formationof bubblesat this particulartime which might precip-
itate the onset of altitude decompressionsickness at the subsequent decom-
pressionfrom 10.2 psi to 4.3 psia. In this test series each of the modified
10.2 psi protocoltests was comparedwith a test on the same subjectfollowing
a 4.0-hour 02 prebreathe (Figure3d). Also in this series,the effect of a
second EVA after a 17-hourintervalwas evaluatedboth with the modified10.2
psiprotocol and the 4.0-hour 02 prebreatheprotocol. Thirty-fivemale sub-
jects were used in this series. Twenty-threeof the subjectswere exposedto
both the modified 10.2 psi protocol and to a 4.0-hour prebreathe protocol.
Twenty-six of the subjects were exposed to second EVA simulationsafter 17
hours; 12 followingthe 10.2 protocoland 14 followingthe 4.0-hourprebreathe
protocol. A total of 89 man tests were conducted in this series. A total of
173 man tests were conductedin the combinedseries.
Series 3 tests were conductedlike the Series 2 tests with the following
changes:
a. The activitiesof the subjectsduring the day prior to the test were
more directly controlled by sequestering the subjects in the JSC health
stabilizationfacility prior to the chamber test. The subjects reported to
the facilityat 5:00 p.m. the day prior to the beginningof the chamber expo-
sure, and their meals and sleepingquarterswere in the facility.
b. The exercise period simulatingEVA was extended to 6 hours. A 20-
minute rest periodwas insertedafter 3 hours. .
c. In those tests involvinga repeated EVA, the followingtimeline was
folIowed:
(1) If the test followeda 4.0-hour02 prebreathe,the subjectswere
returned to 14.7 psia at the end of the first EVA simulation. The subjects
spent the intervening17 hours in the health stabilizationfacilityand then
the chamber exposurewas repeated.
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(2) If the test followed a 10.2 psia protocol,the subjects were
returnedto 10.2 psia at the end of the first EVA simulationand remained in
the chamber for the intervening17 hours prior to a 40-minute02 prebreathe
and_depressurizationto 4.3 psi for the second 6-hour EVA simulation.
RESULTS
, Series 1 Protocol. The resultsof this series are presentedin Table 3.
During the first 5 test exposures,the 10.2 psi protocoldescribedby Figure 1
was followed. Thirteensubjectsunderwentthe test protocoland 3 experienced
decompressionsickness. In 10 of the 13 subjects bubbleswere detected,and
in 8 of the 13 subjects these bubbles were of Grade 3 or 4 (heavy showersof
bubblesor bubblesin all heart cycles).
An incidenceof decompressionsicknesssymptomsof less than 10% had been
expected based on analysis of tests reported in the literature (Figures4 &
5). After five tests had been completed, the results were statistically
incompatiblewith this incidenceof decompressionsickness. Modificationsto
the protocol•were then tried in order to increase the effectivenessof the
denitrogenation. In test #7, the period of stabilizationat 10.2 Psia was
increasedto 18 hours with the rest of the protocol remainingthe same. In
test #7, all these subjects had Grade 3 or 4 bubbles, and two subjects
reportedafter the test that bends pain had occurredduring the test.
in tests #6, #8, #9, and #10, the period of 02 breathingafter 12 hours
at 10.0 psia was increasedfrom 40 minutes to 90 minutes. In tests #6, #8,
and #9, the rest of the protocol remainedthe same. Bends incidencein these
tests was 3 of the 9 subjects,with Grade 3 or 4 bubbles occurringin 5 of the
9 subjects. In test #10, the lower body exercisewas changed from an exercise
involving stepping up a 7 1/2 inch step to a high step-in-placeat the same
rate. Bends incidencewas 1 of 3. The other two subjectswere bends and bub-
ble free. The final four tests, (#11, #12, #13, and #14) were conductedusing
the backup operationalprotocol; 3.5 hours of prebreathingof 02 prior to
decompressionto a suit pressureof 4.3 psia. Eleven subjectswere exposedto
the protocol,and 4 of 11 experiencedbends pain and 7 of 11 had bubbles.
In all the tests in Series 1, symptomsof decompressionsicknessoccurred
in the lower limbs; either knees or feet.
o Table 4 groups the tests of Series 1 into three categoriesby common fea-
tures of the denitrogenationprotocolsand indicatesa similar incidenceof
decompressionsicknessfor each category.
Series 2 Protocol. The overall incidenceof symptoms of decompression
sicknesswas 32% (7 of 22) for the 3.5-hourprotocoland 27% (6 of 22) for the
10.2 psi protocol. (Figure6 and Table 5 present this data in graphic and
tabular format.) This incidencewas very close to that experienced in the
Series 1 testing. The preponderanceof symptoms,7 of 7 at 3.5 psi and 5 of 6
at 10.2 psi, involved the lower extremities;the feet, ankles, and knees
(Table 6). This is also similarto the experiencein the Series 1 tests. In
the 3.5-hour prebreathetests, there was one Grade 3 symptom resulting in a
decisionto removethe subjectfrom the chamberat 2 hours and 30 minutes. In
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the 10.2 psi test series,there was a Grade 3 symptom (effecton performance)
resultingin removalof a subject from the chamber after 1 hour and 50 min-
utes, and a second subject completed the 4.0-hour exercise period but was
classified as Grade 3 based on his post-test comments and the presence of
limpingduring the last 30 minutes. A third subjectwas classifiedas Grade 2
but after pain in the lower limb had cleared severalminutes after recompres-
sion, it reappearedone hour later. This subjectwas treated in the hyper-
baric chamber. Symptomswere relievedat the 60 ft. level on a Table 5 treat-
ment schedule.
Figure 7 illustratesthe elapsedtime to onset of symptomsfollowingthe
two protocols. The mean time of incidenceof symptomsoccurringsubsequentto
the 3.5-hour prebreathe protocol was 138 minutes. The earliest report of
symptomswas at 60 minutes and the latest reportwas at 180 minutes. In one
case, symptomsdisappearedduring the 4.0-hour period. In three other cases,
symptoms abated somewhatduring the 4.0-hour period. In three other cases,
symptoms reached a steady state and continuedat that level until the end of
the test.
The mean time of incidenceof symptomsoccurringsubsequentto the 10.2 psi
prebreathe protocolwas 128 minutes. The earliest report of symptomswas at
18 minutes, and the latest reportwas at 210 minutes. In one case, symptoms
disappearedbut then reappearedat a more severe level which was ultimately
graded level 3 althoughhe completedthe 4 hours. In one other case, symptoms
abated somewhat during the test. In four cases, symptoms progressed or
reached a steady state and persisted at this level. In one case, symptoms
reoccurredafter return to sea level pressureand treatmentin the hyperbaric
chamberwas requiredto resolvethe symptoms.
Series 3 Protocol. The incidenceof decompressionsickness and venous
bubbles in Series 3 test is presentedin Figure 8 and Table 7 and in the fol-
Iowing paragraphs.
The overall incidenceof symptomsof decompressionsicknessduring first
exposures followingthe modified 10.2 psi protocol was 23% (8 of 35). The
overallincidence of symptoms during first exposures following the 4.0-hour
prebreathewas 21% (6 or 28). The incidenceof symptomsafter the second sim-
ulated EVA was 17% followingthe 10.2 psi protocol. During the second simu-
lated EVA followingthe 4.0-hour prebreathe,symptom incidencewas 21%. All
of the symptomsof decompressionsickness in Series 3 tests began in the lower
extremitiesas in the Series 1 and 2 Tests. Followingthe 4.0-hour 02 pre-
breatheprotocol,there was one incidenceof Grade 3 symptom. This was knee
pain which increasedto the point that it interferedwith the performanceof
the subject and caused him to favor that limb in moving about the chamber.
This subjectwas removed from the chamber after 4 hours and 20 minutes expos-
ure at 4.3 psi. This was the only occurrenceof Grade 3 pain in the 89-man
tests in Series 3, and the only test in this series in which the 6-hour simu-
lated EVA was not completed.
Figure 9 illustratesthe difference in the time to onset of symptoms
betweenthe two protocolstested in Series3. Figure 10 illustratesthe onset
times for back-to-backruns.
The mean time of onset of symptoms subsequentto the 4.0-hour 02 pre-
breatheprotoc_olwas 146 minutes comparedto the mean time_:ofonset of symp-
toms in Series 2 subsequentto the 3.5-hour02 prebreatheof138 minutes._The
mean time of onset of symptoms subsequent to the modified 10.2 psi protocol
was.199 minutes compared to 128-144minutes subsequent-to'the basic 10.2 psi
protocol.tested in Series 2 Tests. The mean time of onset of sympt-Omswas 275
minutes in the repeatedEVA runs using the 10.2 psi protocol and 192 minutes
in the repeatedEVA's using the 4.0-hour02 prebreatheprocedure. "°
- DISCUSSION • _ -
Incidenceof Symptoms. -The original plan for the lO.2_psi_denitrogena-
tion protocolcalled for 40-man exposuresto the protocolto assurethat symp-
tom_incidencewas below what was believedto be a conservativeprojection-of
less tha 12% incidenceof-mild symptoms. After one'thirdof theinitial test
serieswas completed, an incidenceof symptoms of 30% led to a-_decisionto
vary the protocoland finallyto includein the tests a 3.5-hour02 prebreathe
prior to decompression. The higher than_anticipatedsymptom incidencecontin-
ued and generatedconcernas to the validityof the test procedure. :_ "
:- '" "" - _ _ _7
" Theresultsof 'Series2 and Series 3 tests were consistent-with,those'of
Series I as far as overall incidenceof symptoms was _concer-ned.: The change
from using a step test in Series 1 tests to upper bo_lyexercise;in.Series2
tests had no-effecton symptom incidenceor on the qocation of symPtoms which
_till occurred primarilyin the lower extremities."The incidenceof symPtOmrS
in Series 3 tests (21%)was_somewhatlower than Series_1 and 2 tests but con-
sistent with theincreased denitrogenationprovidedby both Tthe protocols
tested in series 3 and Still higher than would be expectedfrom an analysis-of
past studies(Hgures°4 and 5). _ " °' - '-'
:: _._
Since the high:-symptomincidence was not a function of the use of a
staged denitrogenationversus a 100% 02 prebreathe,the high incidencerate'in
these studiesmust relate to the nature of the provocativeexposureor-to the
detectionand reportingof symptoms. The componentsof the provocativeexpo-
sure include the protection provided prior to decompressionby denitrogena-
tioni the magnitudeof the changein pressure,the activity of the subjects
during the low 'pressureexposure,and theduration of theexposure. The data
on change in pressureand on extent of denitrogenation'iswell reported:inthe
literature,and these were the factorsused in the predictiveanalysis. How-
ever, it isdifficult to evaluatethe work rates of some of the studiesin the
literature.
- ,-- .
Work Rate. On most past"studies, the intenthas been to simulate the
activity of a flight crew in an aircraft. As a result when significant
exerclse was included in these studies, it was usually in,the form of short
periodsof work with longer periodsof rest betweeneach work period. The EVA
work environment is different. Although average work rates are not high,
activity is almost continuous with short intervals of rest. This was the
nature of the work during the current tests which involved repetitiveupper
body exercise.
In attemptingto replicatethe type of exercise done during extravehicu-
lar activity,attentionwas paid to the overall energy cost of the exercise,
the force of variousmuscle groups on differentjoints, and the rate of repe-
tition of joint flexure. The measurementsof the energy cost of the Apollo
and Skylab EVA's were used as a guide in selectingthe work energy cost of the
activities. Observation of crews practicing EVA activities was used in
determiningthe type and frequencyof limb movement. The activitieswere then
modified somewhatafter crewmenwho had performedactual EVA's evaluatedthese
work tasks. It is likely that the incidenceof symptoms in this test series
is relatedto the exercise which we believe is representativeof that to be
expectedduring EVA.
Durationof Exposure. The first seriesof tests involveda simulatedEVA
period of three hours. In contrast,many of the studiesthat were used in the
predictiveanalysiswere two hours or less in length. The periodof exposure
in test Series 2 and 3 Was extended because of the late appearanceof symp-
toms. In Series 3, three of the 19 symptomswere reportedin the sixth hour.
Reporting of Symptoms. EVeryeffort was made to identify any and all
symptomsof decompressionsickness in these studies. It is possiblethat the
procedures in these tests may have led to greater sensitivityto reporting
minor symptomsof decompressionsickness. In each of the test series, sub-
jects were briefedextensivelyon decompressionsickness. In Series 1 Tests,
we reliedon spontaneousreportingof symptoms. In Series 2 and 3 runs, sub-
jects were asked a standardquestion before the test and at the end of each
hour of the test. In addition,subjectswere encouragedto reportany symptom
or sensationwhen it occurred. Subjectswere instructedto report all unusual
sensationsand that the investigatorwould determinewhether or not the symp-
toms were indicativeof decompressionsickness. All subjects in Series 2 and
3 tests were exposed to at least a 3-hour sea level dry run with the upper
body exercises. During the dry run, the same standardquestionswere asked of
the crewmen. Many of the symptoms reported in this test series during the
altitude chamber exposures were quite mild (Grade 1) and may not have been
reported in studies where a similar emphasis on symptom reporting was not
stressed.
Validityof Symptoms. In order for symptomsto be identifiedas symptoms
of decompression sickness, verificationwas required. The following signs
were consideredverificationof symptoms.
(1) The clear disappearanceof symptomsupon recompression.
(2) The detectionof venous bubbleswith a doppler bubble detector
after movement of the same limb prior to the reportof symptoms.
(3) Progressionand extension of symptoms typical of simple limb
bends.
,--
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In most instancesthere were multiple verificationof symptomsand little
doubt as to their nature. Subjects reporteda completelydifferentsensation
from verified decompression symptoms as compared to sensations of muscle
strain that were noticedduring sea level dry runs and during some altitude
chamber tests. There were two instancesof suspicioussymptoms in"series 3
that were not verified. They disappearedprior to the end of the 6,houriexpo-
sure and were not countedas decompressionsickness.
" Progression of Symptoms. Reportsof decompressionsickness in_theliter-
ature frequentlyinvolve a fairly rapid progressionof_symptoms from mild_to
severe. This was not the case in these series of tests.J In most cases._symp-
toms increasedin severity slowly, if at all; and in somecases, the symptoms
decreasedin severityor disappeared.
Severityof symptoms. In Series I tests, Subjectswere taken out of the
chamberafter identificationof any symptom. However,even in Series 1 Tests,
symptoms were mild and in some cases abort was delayed until it was certain
that symptoms were indeed present. In Series 2 and 3, the symptom grading
shown in Table 2 was utilized and most symptoms were Grade 1 or 2,_ In the
combined 133 Series 2 and 3 Tests, four Grade 3 symptoms occurred (3%) that
interfered with the ability of the subjects to perform their work tasks by
causingthem to limp or favor one limb in the exerciseactivities.
Comparison•of Symptom IncidenceBetween Tests Involving 10.2 psi_:Stage
Decompression and Tests Involving 02 Prebreathe and Between Series 2 and
Series 3 Tests. At the end of the Series 2 Tests, the overal! incidenceof
symptoms after the 10.2 psi staged protocol was similar to the incidenceof
symptoms followingthe 3.5-hour 02 prebreatheprotocol. However,there were
some causes for concern. One of the Grade 3 symptoms•followingthe 10.2 psi
protocolwas a systemic response. This subjectexperienceda sudden onset of
exhaustion in conjunctionwith a cold sweat and a red and white patternof
marbling on the chest, The subjectwas returnedto sea_level._ Thefatigue
and cold sweat disappeared during recompressionto 14.7 psi and the skin
marbling diminishedand disappearedover the next 10-15 minutes, These_symp-
toms are indicativeof a systemic responserelatedto either the cardiopulmo-
nary system or the centralnervoussystem. A secondGrade\3symptom•following
the:lO.2 psi protocolwas due to simple limb bends pain. A third subjectwith
Grade 2 symptomsof mild pain in the knee had a reoccurrenceof pain one hour
after pain disappearedupon recompressionto site pressure. This subjectwas
treated in the hyperbaricchamberwhere the symptom promptly disappeared. A
= fourth subject reported Grade 1 symptoms that were identifiedpost test as
slight sensations of numbness moving from one leg to the other during the
fourth hour of the 4.0-hourexposure. These symptomsmay have been indicative
. of neurologicalinvolvement. Both the subjectwith the systemic responseland
thelsubjectwho experiencedreoccurrenceof pain exhibitedvery high bubbling
rates as measured by the doppler. The subject who experiencedthesystemic
symptomand a subjectin the first series reportedheavy bubblingand symptoms
within the first 20 minutesexposure to decompressionafter the 10,2 psi pro-
tocol. In contrast,after 3.5 hour 02 prebreathing,only symptomsof simple
lim_ bends were seen. Only one Grade 3 symptomwas detected and the earliest
instancesof bubblingor symptomswere later than the comparablevaluesfol-
lowingthe 10.2 psi protocol.
After the completionof the Series 2 Tests, the decision was made to use
the 3.5-hourprotocolin preparationfor the STS-6 EVA and to defer operation-
al use of the 10.2 psi protocol pending additionaltesting on the protocol.
The primaryfactor in this decisionwas the nature and severityof the symp-
toms in some subjectsfollowingthe use of the 10.2 psi protocol. A theory as
to the course of these instancesof severe symptomsis that the initialdecom-
pression from14.7 psi to 10.2 psi resultedin formationor growth of bubbles
that were not resolvedduring the 12-hour period and resulted in early and
rapid developmentof symptomsfollowingthe decompressionfrom 10.2 psi to 4.3
psi. Series 3 tests were conductedto obtain more data on the effectiveness
of the 10.2 psi denitrogenationprotocol. The protocolwas modified by the
additionof one hour of 02 prebreatheprior to the initialdecompressionfrom
14.7 psi to 10.2 psi to reduce the possibility of any bubble formation.
Figure 11 compares the symptom incidence followingthe use of the 10.2 psi
Series 2 protocol with the modified 10.2 psi Series 3 protocol. Although
there was a reduction in overall symptom with the use of the modified
protocol,what is more significant is that the symptoms encountered were
milder, there were no Grade 3 symptoms,and no indicationsof symptomsother
than those of simple limb bends. Additionally,there was an increasedtime of
onset of both bubblesand symptomsusing the modified protocol (Table8), and
also a decrease in the average grade of bubbles (Figure12). The combination
of all these factors indicates that the modified 10.2 psi protocol is
comparableto the use of a 4.0-hour prebreatheand has no tendencyto result
in the more severe symptoms seen after use of the 10.2 psi protocol in the
Series 2 tests.
Figure 13 compares the symptomincidencefollowingthe 3.5-hour protocolwith
the 4.0-hour protocol. There was a reduction in the overall incidence of
symptoms with the additionof a 30-minuteprebreatheperiod, but no reduction
in incidenceof Grade 2 and 3 symptoms,and not much differencein the average
time of onset of symptoms. Some decrease in symptoms was anticipatedand
obtainedwith the addition of 30 minutes prebreathe. There was no indication
from this data of a critical 02 prebreathe duration at 4 hours that
dramaticallyeffectsthe incidenceor severityof symptoms.
Due possibly to the relativelylow number of subjects,a comparison of
symptom incidenceof the four protocolstested in Series 2 and 3 does not show
a statisticallysignificantdifference between the protocols; however, when
all the data on these tests are considered,there is a basis for a conserva-
tive judgment that the modified 10.2 psi and the 4.0-hour 02 prebreathe are
the most operationallyacceptableof the protocols.
Venous Bubbles. An importantdata measurementduring thisstudy was the
detection of bubblespassing through the pulmonary artery after having tra-
versed the heart. The grading system used in the measurementtechnique pro-
vides a semi-quantitiveassessment of the number of bubbles passing through
the heart. The measurement procedure involves sensing of bubbles after
sequentialmovement of limbs with a short, quiet period after each limb move-
ment. Typically, bubbles are detected passing through the pulmonary artery
within a few secondsof limb movementas though the bubbleswere releasedinto
the venous blood stream upon movement of the limb.
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The significance of the presence andquantity of venous bubbles is
relatedto the source of these bubbles and to the competing theories of the
etiology and relationshipof differenttypes of altitude decompressionsick-
ness. The most persuasivetheory as stated by Hills4 is that simple limb
bends pain is caused by extravascularbubbles forming in tissues such as
tendon that restrict the bubbles from expansion and that the pain is the
result of pressure on nerve endings. He has also suggestedthat venous bub-
bles may originatefrom soft tissue with a high nitrogen solubilityand poor
_. perfusionsuch as fat, and that gas expansionin such a tissuewould not apply
pressure on nerve endings but could result in rupture of cell walls and
release of bubbles into capillariesand then through the venous system. If
this were the case, there would be no cause and effect relationshipbetween
" limb bends pain and venous bubbles, and any correlationof bubblesand symp-
toms would be due to parallelformationor growth of bubbles.
An alternatetheory as to the etiology of limb bends pain is that the
symptoms are (in whole or in part) a resultof ischemiafrom bubblesformed or
releasedinto capillariesand blocking oxygenationof tissues. If this were
the case, there might be a cause and effect relationshipor at least a close
relationshipbetween venous bubbles and limb bends pain; however,some of the
characteristicsof limb bends are not explainedby the ischemictheory,
Adams5 has reporteda strong,almost perfectcorrelationbetweenthe limb
from which bubbles were detected and the limb in which symptoms later
appeared. Thisdata is very suggestiveof a close relationshipbetweenbends
symptomsand venous bubbles.
The more serious symptoms of altitude decompressionsickness are also
likely to be relatedto venous bubbles. The lungs can filter large quantities
of bubbles, but there is evidence6 that an overldad of bubbles to the lungs
can result in bubblespassinginto the arterialcirculation..Arterial bubbles
causing ischemiaare very likely the initial cause of central:nervous system
symptomsof decompressionsickness. _
Bubble Incidence. All of the denitr°genati°nprotocols in Series 11-3
resultedin a high incidence(46%to 66%) of venous bubblesas detectedby the
doppler detector. Of the subjects who experiencedbubbles, 47% experienced
symptoms in the same test. Only I of the 45 subjects who experienceddecom-
pression sickness symptomsdid not have bubbles in the same limb prior to the
initial report of symptoms or within a 16-minutedoppler sensor measurement
cycle. This individualhad bubbles detected after movement of the left leg
_" prior to report of Grade 1 symptoms in the right arm but never had bubbles
detectedafter movement of the right arm. This is the same type of relation-
ship betweensite of bubblesand site of symptomsreportedby Adamsb. In most
" cases, bubbling was first detected in the lower limbs; however, it was-very
common for bubblingto spread to other limbs, particularlywhen Grade 3 and 4
bubbleswere detected.
,The average bubble grade experiencedin test Series 1, 2, 3 is presented
as:a.functionof test elapsedtime in Figures14, 15, and 16, The mean bubble
grade was about the same after use of the 3.5-hour02 prebreatheprotocol,the
10.2 psi staged decompressionprotocol,and the 4.0-hour 02 prebreathe. The
10.2_psi protocol resulted in a lower-_ bubble grade. It was not until
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exposure time was extendedto 6 hours in Series3 that a clear patternof bub-
bles diminishingand disappearingbecame clear (Figure 16). Since many sub-
jects experiencedno bubbles and since there is some initiationof bubbling
late in the chambertest, Figure 17 is not representativeof a patternof bub-
ble developmentin an individualsubject. Figure 18 is a plot of the average
bubblegrade in subjectswho experiencedbubbling. The time base is from the
initial detection of bubbles in each subject. This figure accentuatesthe
differencein bubble grade betweenthe 10.2 psi protocol and shows the course
of bubble grade increase and decrease in an exposure where bubbles are
detected. The significanceof this plot is an indicationthat in decompres-
sions of the type in these test series,the processof formationor releaseof
bubbles to the blood stream and transportand removal from the blood in the
lungs depletes the store of dissolved nitrogen in the body so that after a
period of 4 to 5 hours bubbling has greatly diminishedor disappeared. This
decline and disappearanceof venous bubbleshas not been previouslyreported.
The Significanceof Very Heavy Bubbling Detected by the Doppler Sensor.
Very heavy, continuousbubblingmay serve as a warning of the possibilityof
the occurrenceofmore serious forms of decompressionsickness. The one sub-
ject in Series 2 who experiencedsystemicsymptomsand the one subjectwho had
reoccurrenceof symptoms at 14.7 psi both had very heavy Grade 4 bubbling as
detectedby the doppler sensor. The bubblingwas continuouswith and without
limb movements, and the doppler audio signal due to the bubbleswas of such
volume as to completely cover the normal doppler audio signal due to heart
movement. Adams (personalcommunication)has detectedthe same type of heavy
bubblingin one subjectprior to an incidenceof centralnervous system alti-
tude decompressionsickness.
Repeatabilityof Response in an Individual. Table 9 presents the data
from Series 2 with the subjectsarranged in order of the severityof symptoms
in the test exposure of Series 2. This table shows the tendency of subjects
experiencingno symptomsor mild symptoms on one protocol to have a similar
response on the second protocoland for those experiencingmore serioussymp-
toms to experiencemore serious symptomson the second protocol. These tests
were conductedwith an intervalof 5 days to 3 weeks.
Table 10 presents the data on those subjects who participatedin both
Series 2 tests and Series 3 tests in a similar format arranged in order of
severity of symptoms. The repeatabilityof response appearsto be lesspre-
dictable when the interval between exposure is 6 months rather than 1 or 2
weeks, w
Effect of Back-to-BackEVA's on Incidenceand Severity of Bubbles and
Symptoms. Repeated daily exposure to altitude exposures requiring denitro-
genation have been operationally prohibited by both the Air Force in its _-
operationsand by NASA for chamber exposures. A nominal 40-48 hour interval
between exposureshas been required. Adams7 reported an increasedincidence
of altitude decompressionsicknessduring zero prebreatheexposuresto chamber
flightsat 22,000 feet when a physiologicaltrainingtype chamberexposurewas
conducted with subjectsthe precedingday. The basis for concern regarding
repeated decompressionson consecutivedays is that bubbles or bubble nuclei
generatedor increasedin size during the first exposuremight remain in body
tissues and precipitatea rapid growth of bubblesduring the second exposure.
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The _results of our back-to-back exposures, both after 4.0-hour prebreathe
protocols and after modified 10.2 psi protocols, do not lend credence to a
concern regarding daily exposures to our test protocols. The incidence of
bubbles and symptomsduring back-to-back exposures is no greater than during
first exposures (Figure 8). The lower mean grade of bubbles seen in the
repeat tests (Figure 18) and the longer time to onset of both bubbles and
symptoms (Figure 19 and Table 8) indicatethat the reaction to the repeated
exposure after 17 hours is more benign than that to the original.exposure.
OperationalImpact of ReportedSymptom Incidence. The overall incidence
of symptoms in the 173 combinedman tests in Series I, 2, and 3 was 26%. This
is a much higher incidenceof symptoms than had been anticipated. However,
. the majority of these symptoms were minor and did not interferewith the com-
pletion of the simulated EVA. Grade 1 symptoms would have no operational
impact on an EVA. It is very doubtful if these symptomswould be perceptable
to a crewman in a pressure suit. Grade 2 symptoms would have at most a minor
impact on EVA simply due to the presenceof anotherminor ache or pain to con-
tend with in the pressure suit. Finally, the presence of Grade 3 symptoms
would have an effect on EVA through impairedperformanceor the need to abort
the EVA. Of the 132 man runs in the combinedSeries 2 and 3 Tests, there were
four Grade 3 symptoms or 3% of the total.
All of these numbers refer to symptoms of simple limb bends and to a
symptomscale that emphasizesperformanceimpact. However,the rate of occur-
rence of simple limb bends in a populationat risk to decompressionsickness
may be an indicatorof increasedrisk of more seriousforms of altitude decom-
pression sickness involvingthe lung and cardiovascularsystem or the central
nervous system. There was one clear incidentin this test series in which the
limitingsymptomswere systemicratherthan those of simple limb bends and two
less:clear incidences of possiblesystemic response or presystemicresponse
related to either the cardiopulmonarysystem or the central nervous system.
These three incidents all occurred after the use of the unmodifiedI0.2 psi
protocol. There were no similar incidentsfollowinguse of the modified 10.2
psi protocol, the 3.5-hour 02 prebreathe protocol or the 4.0-hour 02 pre-breatheprotocol. '
Altitudechambertests have been conductedat JSC over the past 18 years
with a minimum requirement for 02 prebreathing of 3 hours. In this time
period, severalhundred (conservativelymore than 600) chamber tests have been
conductedwith only two incidencesof bends symptoms,both of which were asso-
ciated with breaks in prebreathe. There have been no incidencesof decompres-
: sion sickness reported in the last 10 years. Many of these tests involved
short exposuresand little activity,but at least one-thirdof these exposures
involved exposures and activities comparableto those in the current study.
- Although some minor symptomsmay have gone unnoticedor unreported,there can
be no doubt that significantcardiovascularor central nervous symptomswould
have been detectedand were not.
It is difficultto estimatethe potentialincidenceof more seriousforms
of decompressionsickness from the results of this study, but the increased
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incidenceof limb bends in a11 of the protocolsused in these studies relative
to the incidenceof limb bends in studies of shorter durationand lower exer-
cise level is a cause for concernas to the potentialfor incidenceof cardio-
pulmonaryor neural symptoms.
CONCLUSIONS:
a. A denitrogenationprotocol (themodified 10.2 psi protocol)that min-
imizes 02 prebreathein the EMU and facilitatesEVA has been definedand veri-
fied to provide protection equivalent or better than that provided by the
3.5-hour02 insult prebreatheused on STS-6.
b. Repetition of a decompressionsimulating that of an EVA after 17 "
hours did not increase the incidence or severity of symptoms or doppler
detected venous bubbles nor did it decrease the time of onset of symptoms or
bubbles.
-c. Symptoms of decompressionsickness in these tests involved primarily
the lower limbs whether exercise included lower body exercise or was limited
primarilyto upper body exercise.
d. In tests involving6-hour simulatedEVA's, there was diminishmentor
disappearanceof doppler detected venous bubbles and stabilizationdiminish-
ment or disappearanceof minor symptomsof limb bends.
e. The incidenceof altitude decompressionsickness in all four of the
major protocolsexamined in this test series was higher than anticipatedprior
to the test initiation. Based on the overall incidenceof symptoms in Test
Series 1, 2, and 3 and on the incidence of symptoms involving performance
decrement in Test Series 2 and 3, there is probability(20-30%) of very mild
symptoms of decompressionsickness,and a possibility(2-3%) of symptomsthat,
if occurringduring an EVA, would requireEVA abort.
RECOMMENDATIONS:
a. It is recommendedthat the modified 10.2 psi protocol,(consistingof
1 hour prebreathe at 14.7 psi, prior to decompressionto a 10.2 psi cabin
pressurewith a 26% 02 concentrationfollowed by a 12-hour exposure and com-
pleted by a 40-minute02 prebreathein the pressure suit) for pre-EVAdenitro-
genation be baselinedfor ShuttleEVA.
_v
b. That the 3.5-hour02 prebreatheprotocolused on STS-6 be retainedas
an acceptablebends preventionprocedurefor single EVA's.
c. That the requirementfor a 40-hour interval betweenEVA's be elimi-
nated; that EVA's be a11owed on consecutivedays; and that a 17-hourinterval
between EVA's be requiredpendingfurthertests to evaluate shorterintervals.
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d. That we pursue and prepare procedures for infltght treatment of
decompressionsickness, should it occur, and that we include the use of hyper-
baric pressures to the extent that can be attained.
e. That we pursue as a goal the developmentof procedures, equipment,
and techniques that wt]l eliminate the need f_r any prebreathing prior to EVA
and eliminate any symptom, regardless of type or level, of decompression
sickness.
I
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Table1
PHYSICALCHARACTERISTICS
SUBJECTS
Male
Series 1 Series2 Series3 Astronauts -
NUMBER OF SUBJECTS 36 23 35
Age - yrs.
Range 21 - 46 21 - 44 22 - 50 28 - 57
33 32 3i 42
% Body Fat
Range 6.0 - 23.0 5.9 - 23.3 6.4 - 25.2 3.0 - 25.6
12.3 11.8 14.2 15
PhysicalActivityScale 0-7
Range 1 - 7 1 - 7 1 - 7 1 - 7
5.1 5.3 4.9 6.1
Weight - Ibs.
Range 123 - 205 128 - 194 140 - 213 124 - 207
164 163 173 166
Height - in.
Range 65 - 76 65 - 74 65 - 74 65 - 72
X 70 70 69 70
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Table 2
SYMPTOMSCALE
0 - No pain or discomfort. No report of pain o[ discomfort.
I - Joint awareness, Reports of awareness or fullness of joints, Subject
does not have discomfort and may not be certain that sensationis other
than a normal feelingdue to fatigue.
2 - Thresholdof pain. Reportingof discomfort,ache, or intermittentpain.
" The sensationdoes not interferewith activity. This feelingmay be lik-
ened by the subjectto the transientpain or stiffnessthat occurs during
warmup exercises.
3 Pain. Reportsof continuouspain ratherthan ache or discomfort. Subject
_cates that pain is just starting to interferewith activity. Some
favoringof affectedlimb is reportedor noticedby observers.
4 - Progressivepain. Reports increased intensityof pain. Subject reports
that pain is affectingperformanceup to 10%. Pain is definitelyworse
with exercise. Observer notices subject to have reluctancein moving a
joint. Subjectmay try to modify exercise regimento avoid pain.
5 - Substantial pain. Subject reports very definite substantial pain in
jolnts. Performancedecrementestimatedto be in range of 10-25%. Obser-
ver noticesa change in activity patternand favoringof affected limb is
readilydiscernible.
6 -Threshold of tolerance. Subject reports that pain is really bad. The
subject prefers to be still and not move. Subject can move extremities
but only with effort. Definitelydoes not want pain to increase.
7 - Disabling pain. Pain is of such intensity that the subject requires
assistancein order to move.
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Table 3
TEST RESULTS
12 hours at 10.2 + 40 minutes02 N = 13
Bends incidence 3/13 23%
Bubble incidence
Grade 3 or 4 8/13 62%
Bubble incidence
Any Grade 10/13 76%
18 hours at 10.2 + 40 minutes O? N = 3
Bends incidence 2/3 66%
Bubble incidence
Grade 3 or 4 3/3 100%
12 hours at 10.2 + 90 minutes 02 N = 9
Step
Bends incidence 4/9 44%
Bubble incidence
Grade 3 or 4 5/9 55%
Bubble incidence
Any Grade 6/9 66%
12 hours at 10.2 + 90 minutes 02 N = 3
Step-in-place
Bends incidence 1/3 33%
Bubble incidence
Grade 3 or 4 1/3 33%
3.5 hours prebreatheon O? N = 11
Bends incidence 4/11 36%
Bubble incidence
Grade 3 or 4 7/11 63%
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Table 4
BENDSINCIDENCEIN BENDSPREVENTIONTEST
N Bends Incidence
12 h'ours or more at 10.2 psia _
+i_40min 02 16 5 31%
" 12 hours at 10.2
90 min 02 12 4 33%
3.5 or more hours 02 at SL 11 4 36%
°
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Table 5
DECOMPRESSIONSICKNESSYMPTOMSSERIES2
3.5 Hour PrebreatheProtocol
95%
Incidence % Confidence
w
Ratio Incidence Limits %
Grade 1 symptomsand bubbles 2/22 9.0% 1 - 29
Grade 2 symptomsand bubbles 4/22 18.0% 5 - 40
Grade 3 symptomsand bubbles 1/22 4.5% 0 - 23
Overall symptomincidence 7/22 32.0% 14 - 55
Bubble incidencewithoutsymptoms 7/22 32.0% 14 - 55
Overall bubble incidence 14/22 64.0% 41 - 82
Subjectsbubble free 8/22 36.0% 17 - 59
10.2 psi PrebreatheProtocol
Grade 1 symptoms and bubbles 2/22 9.0% 1 - 29
Grade 2 symptomsand bubbles 2"/22 9.0% 1 - 29
Grade 3 symptoms and bubbles 2/22 9.0% 1 - 29
Overall symptomincidence 6/22 27.0% 11 - 50
Bubble incidencewithout symptoms 4/22 18.0% 5 - 40
Overallbubble incidence 10/22 45.0% 24 - 68
Subjectsbubble free 12/22 54.0% 32 - 76
Grade 3 symptomsand Grade 2
requiringtreatment 3/22 14.0% 3 - 35
* One case reoccurredpost test requiringhyperbarictreatment
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Table 6
SITE OF SYMPTOMOCCURRENCE
% of Total Symptoms InvolvingEach Area
InitialLocationof Symptoms Series 1 Series 2 Series 3
Lower Body 100% 86% 100%
Upper Body 0% 7% 0%
SimultaneousUpper and Lower Body 0% 7% 0%
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Table 7
BENDSTEST Ill
%
TOTAL Symptoms all (19) 21
N = 89 Gr 1 (5) 6
Gr 2 (13) 15
Gr3 (i) 1
Bubbles (43) 48%
10.2 psi 1st Run Symptoms all (8) 23
N = 35 Gr I (5) 14
Gr 2 (3) 9
Gr 3 (O) 0
Bubbles (20) 57%
10.2 psi 17hr Repeat Symptoms all (2) 17
N = 12 Gr I (O) 0
Gr 2 (2) 17
Gr 3 (O) 0
Bubbles (5) 42%
4hr Prebreathe Symptoms all (6) 21
N = 28 Gr I (O) 0
Gr 2 (5) 18
Gr 3 (I) 4
Bubbles (13) 46%
4hr Prebreathe 17hr Repeat Symptoms all (3) 21
N = 14 Gr I (O) 0
Gr 2 (3) 21
Gr 3 (O) 0
Bubbles (5) 36%
Combined 17hr Repeats Symptoms all (5)
N = 26 Gr I (O) 0
Gr 2 (5) 19
Gr 3 (O) 0
Bubbles (I0) 38%
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iTable 8
TIME OF ONSET OF OF BUBBLES AND SYMPTOMS
r
PROCEDURES N TIME OF FIRST BUBBLE DETECTION N TIME OF FIRST PAIN REPORT
RANGE _ RANGE
f_
10.2 STAGED 10 50 (1-143) 6 128 (18-210)
3.5 HR. PB .... 15 119 (20-221) 7 138 (60-180)
10.2 STAGED + _
60 MINUTE PB 20 126 (24-261) 9 199 (90-329)
4.0 HR._PB . "13, 13 (4-149) i.. 7 146 (50-354)
10.2 'BTO B ......... i5 ....... 145 (106-194) 2 215 (215-336)
4.0 B TO B :5 142 i: (72-221) 3 192 (I05-271)
' 1
r i i i
i I
Table 9
REPEATABILITYOF SYMPTOMSSERIES 2
X = Resultwith 3.5 hours prebreathe
0 = Result with 10.2 equilibr.
@ = 4 hours prebreathe
NUMBER BUBBLES SYMPTOMS 3
0 I 2 3 4 0 I 2 3 4 5 6 7
II X 0 tO
10 0 X tO
7 XO XO
5 XO XO
15 XO XO
22 0 X XO
16 0 X XO
17 XO XO
6 !XO XO
14 = XO XO
18 XO XO
4 XO XO
21 X X
8 "- X 0 X 0
13 XO 0 X
19 0 X 0 X
1 0 X X 0
3 0 XX XO X
12 0 X 0 X
2 XO tO
20 X I 0 0 XIIxo x o
23 ;' I0 : 0
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Table 10
REPEATABILITYOF SYMPTOMSSERIES-TO-SERIES
Series 2 Series 3
Subject No 3.5 10.2 4.0 Repeat4.0 10.2 Repeat 10.2
41 0 0 0 0
33 0 0 0
30 0 0 0
29 0 , 0
37 0,2 0 0
5 2 0 O,f) 0
31 0 1 0
13 0 0 2
10 0 0 0 2 0
8 0 0 2 0
27 0 0 0 2 0
SymptomiGradeO, 1, 2 or 3
- T. _ . .
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Figure i.- Series i test exercises.
26
Figure2.- Series2 and 3 testexercises.
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Figure6.- Bendsincidence10.2psi protocolvs. 3.5-hour02 protocol.
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Figure 7,- Series 2 cumulative incidence of symptoms,
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, Figure 8.- Bends incidence modified 10.2 psi protocol vs. 4-hour 02 protocol.
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Figure 9.- Series 3 cumulative incidence of symptoms.
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Figure i0.- Cumulative incidence of symptoms - back-to-back tests.
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Figureii.-10.2psivs. modified10.2psi protocol-symptomincidence
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Figure 12.-_ Bubble grade 1012 psi protocol vs. modified 10.2 psi protocol.
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Figure 13.- 3.5-hour protocol vs. 4-hour protocol - symptom incidence.
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Figure14.- X Bubble grade as a functionof time - series 1 -
3.5-hourvs. 10.2 psi.
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Figure 15.- X Bubble grade as a function of time - series 2 -
3.5-hourvs. i0.2 psi.
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Figure 16.-_ Bubble grade as a functionof time - series3 -
4-hour vs, modified 10.2 psi.
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Figure 17.- X Bubble incidenceof those who bubbledvs. durationof bubbling.
4"" m ! 4.0 Back-to-Back procedure ' ,,I m N=14'
I I 10.2 Back-to-Back procedure "
3 - I Standard Error H=12
0 1 2 3" 4 5 6 (Hours)
CIIAMBER.TIME ,,
Figure 18.- [ Bubble incidence as a function of time - back-to-back runs.
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